Introduction

CD8
+ T cells play a defensive role against infectious and cancer diseases. Following recognition of foreign antigen (Ag), they undergo 3 distinct phases of immune responses [1, 2] : (i) a proliferation (priming) phase in which naïve CD8 + T cells undergo autonomous clonal expansion and develop into effector cytotoxic T lymphocytes (CTLs); (ii) a contraction phase, in which~9 5% of effector CTLs undergo activation-induced cell death (AICD) through apoptosis, allowing development of ~5-10% memory CTLs; and (iii) a maintenance (memory development) phase in which memory CTLs survive for a prolonged duration. In contrast to their naïve counterparts, memory CTLs respond swiftly by rapid proliferation and heightened effector functions in recall responses to subsequent Ag encounters. [4, 5] . Alternatively, cognate CD4 + T cells have also been shown to initiate a direct signaling in CD40-expressing CD8 + T cells through CD40L costimulation [6] [7] [8] . Although CD4 + T cell help can be dispensable for primary CTL generation, it is prerequisite for programming memory CTLs in most situations [2,6,910.-11] . As the effector phase constitutes both AICD and memory CTL development, APC-stimulated Th cells appear to play a critical role in effector CTL survival and functional memory development [2, 12, 13] . Recently, CD4 + T cell-provided help was shown to support effector CTL survival through the regulation of the TRAIL and Bcl-x L molecules [2, 9, 14] . However, the exact molecular mechanism of CD4 + T cell help that modulates effector CTL survival is still not completely understood.
Intercellular membrane transfer through the process of trogocytosis is a wide-spread phenomenon in the immune system and plays a crucial role in immunomodulation [15] [16] [17] [18] . Recently, acquisition of the Ag-presenting machinery (APM) of APCs by CD4 + T cells has attracted a strong attention [1, 8, 16, [19] [20] [21] [22] [23] [24] [25] , and the functional role of acquired APM is being actively investigated. Although not being efficient in soluble-Ag capture, CD4 + T cells acquire APM from APCs, and present Ags to other naïve CD4 + T cells, inducing their activation and proliferation [8, 17, 25, 26] . In contrast, Ag presentation to previously Agexperienced, activated or memory CD4 + T cells inhibits proliferation, thereby maintaining the homeostasis of immune responses [1, 8, 19, 23] . In our previous reports, we demonstrated the role for CD4 + T cell-acquired APM in modulating responses of naïve CD8 + T cells [8, 21, 27] . We showed that APC-stimulated CD4 + helper T (Th) cells are able to stimulate naïve CD8 + T cells via acquired peptide-major histocompatibility complex-I (pMHC-I) complexes, inducing central memory CTL stimulation and anti-tumor immunity. However, the impact of this acquired APM on the behavior of previously Ag-experienced effector CTLs is not well understood, while this information could be crucial for the development of the successful adoptive CTL cancer therapy.
Here, we generated effector , knockout] mice. We showed that Th cells enhanced CTL survival and their differentiation into functional memory pool, leading to CTL-mediated immune protection against highly metastasizing tumor challenge. In the effector/contraction phase, the inherent ability of CD4 + Th cells to provide IL-2 and CD40L and the low level of acquired pMHC-I complexes was found to be critical for endowing CTLs with survival, and memory development advantages. The down-stream molecular mechanisms underlying the prolonged survival of Th-helped CTLs were also systematically assessed.
Materials and Methods
Ethics statement
All the animal experiments were performed as per the guidelines approved by the University Committee on Animal Care and Supply, University of Saskatchewan. Protocol Number: 20100027.
Reagents, tumor cells and animals
The biotin-and fluorescent dye-labeled (FITC or PE) antibodies (Abs) specific for CD4 (GK1. mice were generated by backcrossing designated gene-deficient mice with OTII mice [8] .
37°C as described previously [21] . OVA-pulsed DCs generated from WT B6 and H-2K [257] [258] [259] [260] [261] [262] [263] [264] tetramer and FITC-anti-CD8 Ab (tetramer assay) [8] . In recall studies, all the groups were boosted i.v. with 1x10 6 DCova 60 days later and monitored for the expansion of memory CTLs on 4 th day by tetramer assay. To phenotypically characterize effector or memory CTLs, the blood samples were collected 6 or 60 days later, and stained for tetramer assay along with panel of biotin-conjugated Abs specific for effector or memory markers, and streptavidin-PE-Texas Red.
Tumor protection studies
To assess functional effect of memory CTLs, approximately 5x10 6 effector CTLs alone that received help during priming period or 5x10 6 effectors CTLs with or without 2x10 /mice), monitored for protection as described previously, and sacrificed later to determine the numbers of surface black tumor colonies in the lungs [8] .
Intracellular IFN-γ staining
On the 24 th day of tumor challenge, the splenocytes of helped or unhelped mice were re-stimulated with OVAI (OVA 257-264 , Multiple Peptide Systems) and subjected to intracellular IFN-γ staining (BDBiosciences) as described previously [27] .
Purification of unhelped or transitionally helped CTLs
The WT and Ia 
qRT-PCR analysis
The cDNA samples of the above three groups of CTLs (helped CTLs in WT or Ia b-/-and unhelped CTLs in Ia b-/-) were further subjected to quantitative RT-PCR (qRT-PCR) for validation of the array results. Sequencespecific primers for β-actin, Bcl-2, FasL and TRAIL were previously described [9, 29] , and for TRAIL receptor, Nfκb1, Bcl10, Akt1, Caspase-4 and -7 were given in supplementary information (Table S1 ). qRT-PCR was performed using SYBR Green method following manufacturer's protocol. Briefly, 20 ng of cDNA, 50nM of each primer and 1X Master Mix (Applied Biosystems) were used in 25 µl volume. The mRNA expressions were analyzed as described for PCR array using β-actin control.
Western blotting
Western blotting was performed in CTLs and unhelped CTLs as described previously with few modifications. The blots were stained with panel of monoclonal-or polyclonal-rabbit Abs specific for Bcl-2 (50E3), β-actin (13E5), Bcl10 (C79F1), Akt1 (2H10), phospho-Akt1 (S473), cleaved Caspase-3 (Asp175) and -7 (Asp198) (Cell Signaling Technology), NF-κB-p65 (C-20), phospho-NF-κB-p65 (Ser536) (Santa Cruz Biotechnology) and NFATc1 (7A6) (BD Biosciences). The blots were incubated with goat anti-rabbit IRDyeR800/680CW, and band densities were quantified using ODYSSEY densitometer (LI-COR Bioscience).
Statistical analysis
The statistical analysis was performed using Graphpad Prism-3.0. The results are presented as mean ± SD. The statistical significance between two or more groups was analyzed by Student's t-test or analysis of variance, respectively. p<0.05 was considered statistically significant.
Results
In line with previous observations [8] , OVA-pulsed bone marrow-derived DCs (DCova), generated in our experiments, expressed all the maturation markers, As previous reports suggest that T-T cell interactions may have immunoregulatory [1, 8, 16, 19, 22, 23, 25] or immunopotentiation [8, 14, 25, 28 ] effects, we sought to determine the functional consequences of Th-CTL interactions during the contraction phase on the fate of CTLs. Particularly, we focused our attention on CTL survival and development into functional memory cells. T cell help delivered during the priming phase was shown to be critical for programming memory CTLs [6,9,10], we also tested this effect in our model using effector CTLs alone or CTLs that received help during in vitro priming. Using the tetramer assay, all the mice were monitored for CTL survival and memory CTL expansion after boosting with DCova (Figure 1b Since a reduced CTL memory pool was observed in the absence of CD4 + T cell help, we compared the phenotypes of helped CTLs in WT mice with unhelped CTLs in Ia b-/-mice at days 6 and 60 following the adoptive effector CTL transfer in an attempt to observe correlations of phenotypic differences with CTL survival rates. On day 6, both helped and unhelped CTLs showed almost equal expression of memory CTL markers CD44 and CD62L although IL-7Rα expression was slightly higher in helped CTLs (18.1%) compared to unhelped CTLs (3.9%) (Figure 1d mice significantly upregulated PD-1 expression (56%) (Figure 1d) .
As the CD40L and IL-2 molecules provided by Th cells and the Th cell-acquired pMHC-I are known to influence CTL priming [8, 31] , survival or memory development [2, [6] [7] [8] 32] , we attempted to determine whether these Th cell-provided signals have any impact on the fate of effector CTLs. It is becoming increasingly clear from various studies [8, 21, 22, 25] (Figure 3a, 3d, 3e ; Table S2a , S2b). Among the up-regulated genes, Caspase family genes, Casp-7, -2 and -3, TNF family members Tnfrsf1a and Trp53, which mediate apoptosis induction, were prominent. Interestingly, 34 genes were found to be significantly down-regulated, of which 24 were prosurvival and 10 were pro-apoptotic genes. Some of the most prominent pro-survival genes down-regulated include Akt1, Api5, Bag1, Bcl-2, Birc3 and 5, Nfκb1, Nol3, Pak7, Pim3, Traf1, and Zc3hc1. The downregulation of some pro-apoptotic genes, although surprising, may represent compensatory mechanisms that occur in cells experiencing various stresses in an attempt to prevent cell death. Second, in contrast to the situation observed in unhelped CTLs, there was a notable shift in the gene-expression profile in helped CTLs, favoring their survival (Figure 3b-3e Table S2a,  S2b) . Interestingly, a considerable overlap was observed in the up-and down-regulated genes in helped CTLs derived from WT and CD4 + T cell-deficient mice (Figure 3d of the anti-apoptotic gene, Dad1, and the pro-apoptotic genes, Casp-2 and Dapk1. Among down-regulated genes, the Caspase superfamily genes, Casp-4, -7 and -3, the TNF superfamily member Tnfrsf10b, and the Caspase recruitment domain superfamily members Card6, and Bcl-10, all involving in apoptosis induction, were observed.
To further provide key insights into the above geneexpression studies, some of the key genes associated with cell apoptosis or survival, such as TRAIL, TRAILrec, Caspase-4, Caspase-7, Bcl-10, Bcl-2, Akt1 and Nfκb1, were further analyzed individually in helped and unhelped CTLs by qRT-PCR using the same cDNA samples. We found that helped CTLs showed upregulation of the prosurvival (Bcl-2, Akt1 and Nfκb1) and down-regulation of the proapoptotic (TRAIL, TRAILrec, Bcl-10, Caspase-4 and Caspase-7) genes ( Figure  3f ). Two major pathways have been reported to be associated with cell apoptosis [33] . These include: (i) the intrinsic pathway, regulated by Bcl-2 family members [34] and the extrinsic pathway, triggered by death receptor (TRAIL)-mediated activation of proCaspase-8, which subsequently activates effector Caspases [35] . We analyzed various key molecules that regulate these pathways, including NFATc1, Bcl-10, Caspase-3, and -7, Bcl-2, NF-κB-p65, Akt1 and TRAIL as well as the phosphorylated form of NF-κB-p65 and Akt1 involved in cell apoptosis or survival were analyzed in helped and unhelped CTLs by Western blotting and flow cytometry. Consistent with PCR array and qRT-PCR results, we found that helped CTLs displayed an increased expression of Bcl-2, Akt1 and NF-κB as well as the phosphorylated-Akt1 and -NF-κB molecules, while reducing expression of NFATc1, Bcl-10, and cleaved Caspase-3 and -7 molecules in comparison to unhelped CTLs ( Figure  4a ). Although some discrepancies between the mRNA and protein levels of NF-κB and Akt1 were observed, these most probably result from posttranscriptional and posttranslational modifications that may interfere with the direct mRNA to protein translation [36] . Furthermore, we found that (Figure 4b ). Our data thus indicate that Th cells could rescue effector CTLs from AICD in the contraction phase by inducing up-regulation of the antiapoptotic genes and down-regulation of the proapoptotic genes, that regulate both intrinsic and extrinsic pathways involved in programmed cell death.
Discussion
Identifying specific factors derived from helper CD4 + T cells involved in the regulation of effector CTL responses is currently one of the most active areas in the immunological research [11] . In the last two decades, the role of signaling by CD4 + T cells through CD40L and IL-2 molecules in the priming phase for memory CTL development has been extensively studied [4, 32, 37] . Tanchot and colleagues and our group previously demonstrated that Th cells can directly provide CD40L [6] [7] [8] and IL-2 [8] to naïve CD8 + CTLs in the priming phase for efficient memory CTL development, whereas de Goer de Herve et al. reported that hetero-specific Th cells can rescue effector CTLs [38] , and promote memory CTL recall responses by direct cellular contact, relying on CD40L and IL-2 signals [38] . It has recently been shown that CD4 + T cell regulation of CTL's IL-2R expression control CTL differentiation and survival [39, 40] , thus indirectly supporting the critical effect of IL-2 on CTL memory. In addition to IL-2, CD4 + Th cell's IL-21 signaling has also been demonstrated to be critical for CD8 + T cell survival [41] . In this study, we demonstrate that cognate CD4 + T cell help required for effector CTL survival and memory programming in the effector phase is also mediated via direct CD40L-and IL-2-induced signaling. In addition, both helped and unhelped CTLs showed almost equal expression of memory CTL markers although IL-7Rα expression was slightly higher in helped CTLs at day 6 subsequent to T cell transfer. It is possible that a slight increase in the IL-7Rα expression in the effector stage (day 6) might have played some role in subsequent survival of helped CTLs as IL-7Rα is known to influence CTL survival [42, 43] ) cells may also be a result of lacking help IL-2 and CD40L signaling [12, 13] . In this study, we also demonstrate that unhelped memory CTLs in Ia b-/-mice expressed inhibitory PD-1 molecule, which is consistent with another recent report by Fuse et al, showing that helpless memory CTLs upregulated PD-1 expression and failed in recall responses [44] . These observations provide a strong evidence to support the recently proposed models, suggesting that both quantity and quality of memory CTLs can be altered in the effector phase [12, 13] We previously demonstrated that CD4 + T cells acquired Ag-presenting machinery such as pMHC-I complexes during DC stimulation [8, 21, 27] . The potential pathways for acquisition of pMHC-I by Th cells include (i) internalization and recycling of synapse composed molecules, (ii) dissociation-associated pathway, and (iii) uptake of DC-released exosomes and Ag peptide [15] . The acquisition of pMHC-I complexes appears to be critical for the ability of Th cells to make efficient contact with CTLs, and to deliver CD40L and IL-2 signaling to these effectors in an Ag-specific manner since, in the absence of pMHC-I, a reduced memory CTL pool exhibiting poor recall functions is observed, indicating the primary role for pMHC-I in targeting CD4 the substantial role of Th cells in rescuing effector CTLs from AICD and in promoting the functional memory generation [2, 14, 41, 46] . Perhaps, even in the classical three-cell interactions, Th cells, after detaching from DCs, might directly act on CTLs in the vicinity due to pMHC-I and TCR avidities. Recently, the role for cognate Th cells, acting through the secretion of IFN-γ and chemokines was proposed in mobilizing differentiated effector CTLs into infected tissues [47] . It is very likely that these factors, together with highaffinity pMHC-I and TCR interactions, greatly favor the ability of Th cells to deliver CD40L and IL-2 signals directly to effector CTLs in vivo.
Previous reports [38] together with our current study demonstrate that Th cells appear to mediate CTL survival by secreting survival factors, such as IL-2, and by providing costimulation signals including CD40L. However, the intracellular molecular mechanisms, underlying the Th-mediated CTL survival are not completely understood. Recently, CD4 + T cell-provided help was shown to be required for effector CTL survival via the regulation of TRAIL and Bcl-x L [2, 9, 14] . In this study, we performed a more systematical assessment, based on the gene-expression profiling by PCR array, to provide mechanistic insights into the molecular organization of CD4 + T cell help effects on CTL fates. Our data show that the poor survival of unhelped CTLs correlates well with the down-regulation of key survival genes, which mediate signals both at nuclear and cytoplasmic levels, that are required for the activation of the pro-survival NF-κB and attenuation of the proapoptotic JNK pathways [48] . In contrast, helped CTLs display an increased activation of Akt1 and NF-κB proteins, inducing transcription of various survival genes [48, 49] . Interestingly, increased expression of survival genes was not a unique feature of helped effector CTLs, as their mRNA profiles characterized by pro-survival gene expression patterns were almost identical to those of naïve OTI CD8 + T cells. A few genes up-regulated above naïve T cell levels, including Akt1, Xiap, CD40lg and Traf1, might have played a leading role in the effector CTL survival. The serinethreonine kinase Akt1, for example, executes potent antiapoptotic effects by inhibiting a cohort of cell death-inducing molecules and activating multiple antiapoptotic factors [50, 51] . Akt-1 is shown to activate Inhibitor of NF-κB kinase (IKK), which enables the translocation of NF-κB to the nucleus where it drives the transcription of antiapoptotic genes such as Bcl-2 and Bcl-X L [50, 52, 53] . More recently, it has also been demonstrated that Th-derived IL-21 triggers the activation of the STAT1 and STAT3 pathways and increases expression of the prosurvival molecules Bcl-2 and Bcl-xL in CD8 + T cells, leading to efficient CTL survival [41] . Our data are thus consistent with a previous report, showing that down-regulation of Notch-1 and Jagged-1 induces the cell intrinsic apoptotic pathway via the inactivation of Akt and NF-κB [54] . It was previously shown that memory CD8 + T cells lacking CD4 + T cell help express TRAIL and die by TRAIL-mediated cell death [9, 55] . In this study, we demonstrate that unhelped effector CD8 + T cells also express TRAIL, indicating that TRAIL-mediated extrinsic apoptotic pathway appears to be another key mediator in the contraction of adoptively transferred effector CTLs.
Adoptive CD8 + T cell therapy refers to an immunotherapy approach in which tumor-infiltrating lymphocytes (TILs) isolated from tumor specimen are activated and expanded in vitro to large quantities, using anti-CD3/CD28 antibodies and IL-2, and then transferred back to the cancer patients [56] . Alternatively, CTL clones derived from TILs or T cell clones engineered to express recombinant TCR specific for tumor Ag could be used for the adoptive T cell therapy [57] [58] [59] [60] [61] . To date, the adoptive CTL cancer immunotherapy, relying on in vitro-expanded tumorinfiltrating CD8 + T cells, has achieved some degree of success [62, 63] . However, one of the major obstacles in this therapy is the poor survival of transferred TILs or CTL clones, and the development of corrupted CTL memories [62, 63] due to AICD and the CD4 + T celldeficient environment, typically associated with primary cancer therapies [18, 33] . It has been demonstrated that effector CD4 + T cells promoted CTL survival and tumor localization via rendering tumor environment permissive in the course of adoptive CTL therapy [2, 64] . Therefore, the poor survival of unhelped CTLs associated incomplete protection against lethal tumor challenge shown in this study reemphasizes the importance of either using Th cells in TIL preparation or co-transferring TILs with Th cells into cancer patients during the adoptive CTL therapy.
Taken together, our results reveal a previously unexplored mechanism of Th cell action in programming CTL responses. The observed Th celleffector CTL cooperation could explain why memory CTLs, generated under cognate Th cell help, obtain significant survival and recall advantages. Moreover, this knowledge could aid in the development of efficient adoptive CTL cancer therapeutics. 
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